PD-Rx Recalls Losartan Potassium Tablets Due to Trace NMBA Contamination
PD-Rx Pharmaceuticals is recalling Losartan Potassium 50 mg tablets because they contain trace amounts of NMBA, a potential carcinogen.
- Product
- LOSARTAN POTASSIUM — LOSARTAN POTASSIUM (LOSARTAN POTASSIUM)
- Category
- Drug
- Distribution
- 14 states